Case | Gender | Age(yrs) | Site | Pathological diagnosis | Primary replacement | Survival time of endoprosthesis (yrs) | Type |
---|---|---|---|---|---|---|---|
1 | male | 49 | R | OS | RHP | 2 | I |
2 | male | 22 | L | OS | RHP | 1 | I |
3 | male | 33 | L | GCT | RHP | 4 | I |
4 | male | 15 | R | OS | RHP | 4 | I |
5 | male | 64 | R | GCT | RHP | 3 | I |
6 | male | 59 | R | GCT | FHP | 11 | I |
7 | male | 17 | R | OS | RHP | 5 | I |
8 | male | 45 | R | CS | FHP | 1 | I |
9 | female | 46 | R | DF | FHP | 13 | I |
10 | female | 49 | R | GCT | RHP | 15 | I |
11 | female | 33 | R | GCT | RHP | 13 | I |
12 | male | 49 | L | MFH | RHP | 3 | I |
13 | male | 40 | L | GCT | RHP | 11 | IIa |
14 | male | 37 | L | GCT | FHP | 14 | IIa |
15 | female | 25 | L | OS | RHP | 8 | IIa |
16 | male | 31 | L | OS | RHP | 4 | IIa |
17 | female | 38 | R | OS | RHP | 11 | IIa |
18 | female | 64 | R | GCT | FHP | 20 | IIa |
19 | male | 39 | R | GCT | RHP | 7 | IIa |
20 | male | 58 | L | MPNST | RHP | 3 | IIb |
21 | male | 40 | L | GCT | RHP | 11 | IIb |
22 | female | 38 | R | GCT | FHP | 10 | IIb |
23 | male | 50 | L | GCT | RHP | 14 | IIb |
24 | male | 53 | L | GCT | RHP | 9 | IIb |
25 | male | 54 | L | GCT | RHP | 12 | IIb |
26 | female | 60 | L | GCT | FHP | 27 | IIb |
27 | male | 31 | L | OS | FHP | 14 | III |
28 | male | 48 | L | GCT | RHP | 13 | III |
29 | female | 75 | L | GCT | RHP | 14 | III |
30 | male | 58 | L | GCT | RHP | 7 | III |
31 | female | 56 | L | OS | RHP | 7 | IV |